SfRowasa 4 GM in 60 mL Enema
RxNorm 206798
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 206798 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: sfRowasa 4 GM in 60 mL Enema.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDPrescribable
Semantic Branded Drug (SBD):
Mesalamine 66.7 mg/ML Enema [Rowasa]
(Atom ID: 2357155)
SYPrescribable
Synonym (SY):
Rowasa 4 GM per 60 mL Enema
(Atom ID: 3027514)
SYPrescribable
Synonym (SY):
Rowasa 66.7 mg/ML Enema
(Atom ID: 1154059)
PSNPrescribable
Prescribable Name (PSN):
SfRowasa 4 GM in 60 mL Enema
(Atom ID: 13050168)
SYPrescribable
Synonym (SY):
SfRowasa 4 GM per 60 mL Enema
(Atom ID: 3029125)
Patient Education
Mesalamine Rectal
Rectal mesalamine is used to treat ulcerative colitis (a condition which causes swelling and sores in the lining of the colon [large intestine] and rectum), proctitis (swelling in the rectum), and proctosigmoiditis (swelling in the rectum and sigmoid colon [last section of the colon]). Rectal mesalamine is in a class of medications called anti-inflammatory agents. It works by stopping the body from producing a certain substance that may cause inflammation.
[Learn More]
* Please review the disclaimer below.